Fyremadel (F)
Fyremadel (F)
Product Description
Each pre-filled syringe contains 0.25 mg of ganirelix (as acetate) in 0.5 ml aqueous solution
Fyremadel 250mcg solution for injection in pre-filled syringe is indicated for the prevention of premature luteinising hormone (LH) surges in women undergoing controlled ovarian hyperstimulation (COH) for assisted reproduction techniques (ART).
In clinical studies ganirelix was used with recombinant human follicle stimulating hormone (FSH) or corifollitropin alfa, the sustained follicle stimulant.Directions
Available on request.Ingredients
Available on request.Product Details
Form:Syringe (Pre-filled)Fridge-line:NoMarketing Authorisation:PL-Available on RequestToxin:NoPOM:YesLegal Category:POMFiller:NoStorage Temperature:N/AManufacturer:N/A